ACZ885

canakinumab · Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

18 regulatory and trial events tracked for ACZ885, covering 2007-12-28 to 2021-07-09. Get the full timeline:

Most recent: Clinical Trial Update: Long-term Efficacy, Safety and Tolerability of ACZ885 in Patients With Rheumatoid Arthritis [Phase 2]